ADVERTISEMENT
Pituitary pars intermedia dysfunction (PPID, or equine Cushing’s disease) has been a challenge for horse owners and veterinarians for years. As researchers learn more information about it, the clinical signs of PPID are becoming more recognizable in horses.
However, there are still several other misconceptions or myths about the disease. Here, Steve Grubbs, DVM, PhD, Dipl. ACVIM, equine technical manager for Boehringer Ingelheim Vetmedica, Inc., dispels some of the most common misconceptions.
Misconception: PPID is only a condition of the geriatric horse.
Yes, PPID is common in senior horses. But, that it only imacts older animals “is probably one of the most common myths about PPID,” Grubbs says. “We have been tracking epidemiological information on horses diagnosed with PPID, and have found that PPID affects horses of all breeds, and all ages, even as young as 5 years old.”
Survey aims for insight into how owners comply with administering medication and their capacity to feed PPID horses separately, as well as the costs and the side-effects of medications.
Search jobs 17-Mar-2021 Swine Respiratory Disease Treatment Market Size, Historical Analysis, Emerging Trends, Future Scope and Opportunity to 2026
SEATTLE, March 17, 2021, (PHARMIWEB) Swine respiratory disease affects the respiratory tract of swine. It is one of the prevalent cause of death in nursery pigs and grower/finisher pigs. There are multiple pathogens, viruses, and other secondary causative agents that causes respiratory disease in swine. Primary pathogens that causes swine respiratory disease include Actinobacillus pleuropneumoniae (APP), Mycoplasma hyopneumoniae, Bordetella bronchiseptica, and Pasteurella multocida. Viral agents involved includes porcine reproductive and respiratory syndrome (PRRS) virus and swine influenza virus (SIV). Various diseases that come under ambit of swine respiratory disease include mycoplasma pneumonia, swine influenza, classical swine fever atrophic rhinitis, pleuropneumonia, porcine reprod
Search jobs 22-Feb-2021 Veterinary Vaccine Market will grow at 6.2% CAGR, to be valued at US$ 11,627.46 Million by 2027
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), By Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 6,766.5 million in 2018 and is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027).
Global Animal Therapeutics and Diagnostic Market Analysis 2021 Trends, Industry Growth, Opportunities Forecast To 2026 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.